Concepedia

Kevin Lou

KL

Statistics

Publications

11

Citations

5.9K

H-Index

10

Active since

2012

Affiliations

University of California, San Francisco(Current)

Howard Hughes Medical Institute

UCSF Helen Diller Family Comprehensive Cancer Center

University of California, Berkeley

University of Pennsylvania

Kevin Lou is an author at University of California, San Francisco specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2012–2022

11

Publications

11

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou et al. · Nature · 2020 · 4.8K citations · Full text

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

David E. Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou et al. · 2020 · 453 citations · Full text

p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition

Keelan Z. Guiley, Jack W. Stevenson, Kevin Lou et al. · Science · 2019 · 226 citations · Full text

, , +17

KRAS <sup>G12C</sup> inhibition produces a driver-limited state revealing collateral dependencies

Kevin Lou, Veronica Steri, Alex Y. Ge et al. · Science Signaling · 2019 · 176 citations · Full text

Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies

Kevin Lou, Yuemang Yao, Adam T. Hoye et al. · Journal of Medicinal Chemistry · 2014 · 90 citations · Full text

, , +21

1–5 of 11